NCT00004689View on ClinicalTrials.gov

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 31, 1991

Study Completion Date

September 30, 1998

Conditions

Mycobacterium Avium-intracellulare Infection

Interventions

DRUG

amithiozone

DRUG

clarithromycin

DRUG

ethambutol

DRUG

rifampin

DRUG

streptomycin

All Listed Sponsors

lead

National Jewish Health

OTHER